Skip to main content
. 2020 Jan 29;2020(1):CD012988. doi: 10.1002/14651858.CD012988.pub2

NCT03953157.

Trial name or title Dietary and exercise interventions in reducing side effects in patients with stage I‐IIIa breast cancer receiving aromatase inhibitors
Methods RCT
Participants 20 participants, on an AI for at least 6 months, with mild/moderate arthralgia for at least 2 months as determined by BPI
Interventions Anti‐inflammatory diet vs exercise programme
Outcomes Primary outcomes
  • BMD

  • Joint and muscle pain via BPI and VAS

  • Grip strength

  • Inflammatory markers

Starting date 1 August 2019
Contact information Catherine L Carpenter: 3108258499; ccarpenter@sonnet.ucla.edu
Notes USA